UK Biotech, Chinese Manufacturer Prime IPOs Totaling $82M
Verona Pharma PLC, a U.K. biotech firm developing treatments for respiratory diseases, launched a U.S. initial public offering on Tuesday that aims to raise $75 million, guided by Latham & Watkins...To view the full article, register now.
Already a subscriber? Click here to view full article